|
| Tuesday, 15 June 2010, 16:53 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
SINGAPORE, June 15, 2010 - (ACN Newswire) - The Singapore Agency for Science, Technology and Research (A*STAR) will be at CommunicAsia 2010 to showcase more than ten innovative market-ready technologies, from 15 to 18 June 2010 at Singapore Expo Hall 3, Booth 3D1-01.
Amongst the technologies making their debut at the mega ICT event are a group of personal 3D entertainment technologies developed by researchers from A*STAR's Institute for Infocomm Research (I2R). These technologies can be integrated into a number of products and services that will further the creation and enjoyment of 3D in the home. The Dance! 3D, for example, simulates a dance floor environment and allows a player to have a natural and intuitive live dance interaction with customisable virtual characters. Meanwhile, the 3D Face Modelling Web service takes a 2-dimensional frontal portrait image and instantaneously processes it into a full 3-dimensional face object file that can be incorporated into games, virtual worlds, and other applications involving photo-realistic human avatars.
These are just two of the many equally impactful A*STAR's technologies that will be showcased at CommunicAsia 2010. Exploit Technologies, the commercialisation arm of A*STAR, will be available onsite to discussion collaboration and licensing opportunities.
Mr Philip Lim, Chief Executive Officer of Exploit Technologies, said, "A*STAR is showcasing a very strong pipeline of market-ready technologies in the upcoming CommunicAsia. The focus on infocomm technologies that enhance lifestyle, communications and enterprise operations is in line with the market's new growth areas. We strongly encourage all industry players to visit our booth at CommunicAsia to explore potential collaboration opportunities. It is only by working together that we can maximise our commercialisation success and get good technologies into the marketplace."
Added Prof Lye Kin Mun, Acting Executive Director of I2R, "With today's lifestyle needs, any solution that benefits or enhances the end-user experience are very much sought after in this fast paced world. These practical solutions from our R&D efforts will be showcased at this exhibition. In addition, I2R seeks to develop new Infocomm and media technologies that serve up the best experience by improved connectivity, interactivity and enhanced communications for our global partners."
The exhibition will have on display and for licensing, technologies in three main application areas, namely:
1. Lifestyle
- 3D Face Modelling Web service
- Dance! 3D
- Intelligent Gesture-based Information Kiosk
- Network-Adaptive Audio Streaming in HD based on MPEG-4 SLS Scalable Lossless
- Scalable Media Gateway (powered by A*SMP)
2. Communications
- Active Tag and System
- Flexible RFID Middleware
- Fault Diagnosis Module for Optical Networking Terminals
- Maritime Mobile Mesh Network
3. Enterprise
- Digital forensic evidence & file recovery system
Besides the ten technologies, a group of A*STAR's start-ups and licensees will introduce their products and services at the event. These include Compex Systems Pte Ltd, FXMedia Internet Pte Ltd, iTwin Pte Ltd, Knorex Pte Ltd, Signature Music Technologies Pte Ltd, Niometrics Pte Ltd and XYZ Wave Pte Ltd.
All media representatives and photographer/film crews are cordially invited to visit A*STAR's booth at CommunicAsia 2010, from 15 to 18 June 2010 at Singapore Expo Hall 3, Booth 3D1-01.
About Exploit Technologies Pte Ltd
Exploit Technologies is the strategic marketing and commercialisation arm of the Agency for Science, Technology and Research (A*STAR). Its mission is to support A*STAR in transforming the economy through commercialising R&D. Exploit Technologies enhances the research output of A*STAR scientists by translating their inventions into marketable products or processes. Through licensing deals with industry partners and spinoffs, Exploit Technologies is a key driver of technology transfer in Singapore. It actively engages industry leaders and players to commercialise A*STAR's technologies and capabilities, bridging the gap from Mind to Market. Exploit Technologies' charter is to identify, protect and exploit promising intellectual property (IP) created by A*STAR's research institutes. For more information, please visit www.exploit-tech.com.
About Institute for Infocomm Research
The Institute for Infocomm Research (I2R - pronounced as i-squared-r) is a member of the Agency for Science, Technology and Research (A*STAR) family. Established in 2002, our mission is to be the globally preferred source of innovations in `Interactive Secured Information, Content and Services Anytime Anywhere' through research by passionate people dedicated to Singapore's economic success. I2R performs R&D in information, communications and media (ICM) technologies to develop holistic solutions across the ICM value chain. Our research capabilities are in information technology, wireless and optical communication networks, interactive and digital media; signal processing and computing. We seek to be the infocomm and media value creator that keeps Singapore ahead. Website: www.I2R.a-star.edu.sg.
Contact:
Wei Peng (Ms)
Exploit Technologies Pte Ltd (A member of A*STAR)
Vice President, Corporate Communications
DID: +65 6478 8443
Email: weipeng@exploit-tech.com
Andrew Yap (Mr)
Manager, Corporate Communications
Science and Engineering Institutes for Institute for Infocomm Research (I2R)
DID: +65 6419 1143
Email: yapjt@scei.a-star.edu.sg
Topic: New Product
Source: A*STAR
Sectors: Film & Video, Consumer Electronics, Broadcast, Film & Sat
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
